Medicare Enrolled
Dr. Kiavash Nikkhou, M.D.
Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nikkhou from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nikkhou?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nikkhou
Dr. Kiavash Nikkhou is an urology physician in Los Angeles, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Nikkhou performed 8,228 Medicare services across 3,223 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nikkhou received a total of $8,436 from 62 pharmaceutical and/or device companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nikkhou is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 13% volume in CA
$8,436 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,228
Medicare services
Top 13% in CA for urology physician
3,223
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~748 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,115 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,663 | $72 | $145 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
700 | $3 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
513 | $102 | $220 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
483 | $9 | $115 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 281 | $134 | $600 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
218 | $84 | $300 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
175 | $217 | $425 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $130 | $311 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
107 | $30 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
103 | $67 | $125 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
86 | $76 | $340 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
77 | $11 | $265 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
76 | $17 | $50 |
| Simple change of bladder tube | 66 | $80 | $300 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
62 | $52 | $225 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
52 | $144 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
51 | $12 | $55 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
29 | $52 | $170 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $108 | $450 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
25 | $26 | $375 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $21 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $46 | $95 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $149 | $300 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
19 | $996 | $7,300 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
19 | $126 | $375 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
18 | $612 | $2,800 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
17 | $279 | $3,330 |
| Insertion of temporary bladder tube | 16 | $40 | $210 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $97 | $850 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
14 | $27 | $50 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $290 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
9.3% medium
90.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,436
Total received (2018-2024)
Avg $1,205/year across 7 years
Top 24% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
375
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,945 (94.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$491 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$499
2023
$1,377
2022
$1,216
2021
$1,050
2020
$1,095
2019
$2,133
2018
$1,066
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$177
Bayer Healthcare Pharmaceuticals Inc.
$53
Laborie Medical Technologies Corp.
$47
Sumitomo Pharma America, Inc.
$45
PROGENICS PHARMACEUTICALS, INC.
$42
IMMUNITYBIO, INC.
$26
Endo USA, Inc.
$24
Astellas Pharma US Inc
$24
PFIZER INC.
$23
Agiliti Surgical, Inc.
$20
PROCEPT BioRobotics Corporation
$18
Top 3 companies account for 55.6% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$948
Astellas Pharma US Inc
$766
ABBVIE INC.
$636
PFIZER INC.
$630
Blue Earth Diagnostics Limited
$437
AbbVie, Inc.
$349
Coloplast Corp
$322
Janssen Biotech, Inc.
$316
Rochester Medical Corporation
$312
Amgen Inc.
$301
PROCEPT BioRobotics Corporation
$273
Endo Pharmaceuticals Inc.
$227
COLOPLAST CORP
$219
C. R. Bard, Inc. & Subsidiaries
$172
Progenics Pharmaceuticals, Inc.
$164
Myriad Genetic Laboratories, Inc.
$135
BIOTISSUE HOLDINGS, INC.
$133
Antares Pharma, Inc.
$126
Sumitomo Pharma America, Inc.
$121
Boston Scientific Corporation
$115
Takeda Pharmaceuticals U.S.A., Inc.
$111
Merck Sharp & Dohme Corporation
$98
Myovant Sciences Inc.
$98
AbbVie Inc.
$94
BioTissue Holdings, Inc.
$89
Bayer HealthCare Pharmaceuticals Inc.
$88
Biohaven Pharmaceuticals, Inc.
$69
Merck Sharp & Dohme LLC
$63
Allergan Inc.
$56
Bayer Healthcare Pharmaceuticals Inc.
$53
Lilly USA, LLC
$50
Avadel Specialty Pharmaceuticals, LLC
$49
Laborie Medical Technologies Corp.
$47
Teleflex LLC
$43
UROVANT SCIENCES INC
$43
PROGENICS PHARMACEUTICALS, INC.
$42
IBSA Pharma Inc.
$38
Shield Therapeutics Inc
$38
MEDIVATION FIELD SOLUTIONS LLC
$38
Olympus America Inc.
$38
Janssen Pharmaceuticals, Inc
$37
Cook Medical LLC
$35
TOLMAR Pharmaceuticals, Inc.
$34
180 Medical, Inc.
$29
IMMUNITYBIO, INC.
$26
Axonics, Inc.
$25
Endo USA, Inc.
$24
MAYNE PHARMA INC.
$24
UroGen Pharma, Inc.
$24
Supernus Pharmaceuticals, Inc.
$23
Dendreon Pharmaceuticals LLC
$22
Zyla Life Sciences
$22
Agiliti Surgical, Inc.
$20
NeoTract Inc.
$19
Metuchen Pharmaceuticals
$17
TherapeuticsMD, Inc.
$17
AMAG Pharmaceuticals, Inc.
$17
Tolmar, Inc.
$17
AKRIMAX PHARMACEUTICALS, LLC
$16
EDAP TECHNOMED INC
$15
Exact Sciences Corporation
$14
Clarus Therapeutics Inc.
$13
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axumin · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · Bard Urinary Drainage Bag · Bulkamid · CONTINENCE CARE · COOK MEDICAL UROLOGY · Cologuard Collection Kit · Cook · Da Vinci Surgical System · ELIGARD · EMGALITY · ERLEADA · EVENITY · Erleada · GEMTESA · IMVEXXY · INTRAROSA · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYFEMBREE · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · NURTEC ODT · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Olympus Cystoscopes · Optilume BPH Drug Coated Balloon Catheter · PAXLOVID · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SPACEOAR · SPEEDICATH · SPRIX · Sonablate HIFU · SpeediCath · Stendra · TOVIAZ · TRINTELLIX · Tirosint · UROLIFT · UroLift · XARELTO · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
411
Per 100K population
4.2
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nikkhou is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nikkhou experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Nikkhou performed 3,115 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nikkhou receive payments from pharmaceutical companies?
Yes. Dr. Nikkhou received a total of $8,436 from 62 companies across 375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nikkhou's costs compare to other urology physicians in Los Angeles?
Dr. Nikkhou's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nikkhou) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Los Angeles
Browse urology physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology